Compare Hilton Hotels Corporation Common Stock (HLT) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hilton Hotels Corporation Common Stock vs Twist Bioscience Corp — how do they compare? Hilton Hotels Corporation Common Stock trades at $323.94 (market cap $73.63B), while Twist Bioscience Corp trades at $88.31 (market cap $5.45B). The key difference: Hilton Hotels Corporation Common Stock is far larger — about 13.5× Twist Bioscience Corp's market cap, and Hilton Hotels Corporation Common Stock pays a 0.19% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| HLT | TWST | |
|---|---|---|
Market Cap | $73.63B | $5.45B |
Sector | Consumer Cyclical | Health |
52-Week High | $350.22 | $102.88 |
52-Week Low | $256.75 | $24.16 |
Enterprise Value | $86.12B | $5.37B |
Dividend Yield | 0.19% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hilton Worldwide (HLT) trades at $323.94, up 0.82% with a bearish technical signal despite recent earnings beats. Revenue grew to $12.04B in 2025 with a net income margin of 12.56%, though the P/E ratio of 49.38 suggests premium valuation. The stock faces headwinds from negative equity and rising debt-to-asset ratio, now at 73.88% for 2025. Analyst consensus remains bullish with a $343.40 price target, and recent news highlights earnings optimism ahead of Q2 2026 results.
Outlook: Strong travel demand and consistent earnings beats support growth, but high leverage and valuation pose risks. Opportunities include brand expansion and operational efficiency, while risks involve debt servicing and economic sensitivity. Investors should weigh analyst optimism against fundamental pressures.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hilton Hotels Corporation Common Stock
Hilton Worldwide Holdings operates 1,074,791 rooms across its 18 brands addressing the midscale through luxury segments as of Dec. 31, 2021. Hampton and Hilton are the two largest brands by total room count at 28% and 21%, respectively, as of Dec. 31, 2021. Recent brands launched over the last few years include Home2, Curio, Canopy, Tru, and Tempo. Managed and franchised represent the vast majority of adjusted EBITDA, predominantly from the Americas regions.
Read more on HLT →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
